CIK: 1401018 - Address: C/O Vor Biopharma Inc., 100 Cambridgepark Drive, Suite 101, Cambridge, MA 02140
23 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1112-1-462-20-33-8
S%wins755842588310069

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/12/19 17:32
11/8/19
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagPatterson Matthew RCADOCEOS.d-43330.000-14-5285D
8/14/19 19:03
8/12/19
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagPatterson Matthew RCADOCEOS.d-68134.040-20-7287D
2/27/19 16:31
2/25/19
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagPatterson Matthew RCADOCEOS.d-63030.000-21-7291D
10/2/18 19:04
10/1/18
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagPatterson Matthew RCADOCEOS.d-80138.160-21-10187D
9/20/18 19:01
9/18/18
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagPatterson Matthew RCADOCEOS.d-51840.000-13-7172D
7/5/18 18:34
7/2/18
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagPatterson Matthew RCADOCEOS.dm-2,81039.550-71-29172D
5/23/18 18:13
5/21/18
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagPatterson Matthew RCADOP,CEOS.d-77438.150-20-11172D
4/4/18 21:01
4/2/18
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagPatterson Matthew RCADOP,CEOS.d-2130.010-10172D
10/4/17 20:25
10/2/17
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagPatterson Matthew RCADOP,CEOS.d-69827.920-25-13172M
9/19/17 18:00
9/15/17
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagPatterson Matthew RCADOP,CEOS.dm-25125.060-10-5187D
7/14/17 20:01
7/12/17
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagPatterson Matthew RCADOP,CEOS.m-30020.000-15-7187I
11/3/08 14:56
10/30/08
FOLDAmicus Therapeutics IncDEHealthDrugPharmaceutical PreparationsPatterson Matthew RNJOCOOS.m-2310.000-2-636D-343-31-36-17631-2-15-20-3-19-61
10/24/08 15:21
10/22/08
FOLDAmicus Therapeutics IncDEHealthDrugPharmaceutical PreparationsPatterson Matthew RNJOCOOS.m-3310.390-3-839D-39-4-34-29-32-18-8-7-2-16-12-15-58
10/22/08 15:41
10/20/08
FOLDAmicus Therapeutics IncDEHealthDrugPharmaceutical PreparationsPatterson Matthew RNJOCOOS.m-4810.620-5-1042D-3717-29-29-30-16-4-5-23-15-22-17-59
8/21/08 17:22
8/20/08
FOLDAmicus Therapeutics IncDEHealthDrugPharmaceutical PreparationsPatterson Matthew RNJOCOOS-2713.541-2-446D17333314-11-21-163417-31-23-24
8/20/08 17:11
8/18/08
FOLDAmicus Therapeutics IncDEHealthDrugPharmaceutical PreparationsPatterson Matthew RNJOCOOS.m-11614.451-8-1448D20463620-6-16-17-2218-33-28-23
7/22/08 16:22
6/18/08
FOLDAmicus Therapeutics IncDEHealthDrugPharmaceutical PreparationsPatterson Matthew RNJOCOOS.am-2111.010-2-358D23353741362010-21-7-32-50-31
7/22/08 16:22
6/20/08
FOLDAmicus Therapeutics IncDEHealthDrugPharmaceutical PreparationsPatterson Matthew RNJOCOOS.a-1611.400-1-256D23353741362010-21-7-32-50-31
6/24/08 16:20
6/20/08
FOLDAmicus Therapeutics IncDEHealthDrugPharmaceutical PreparationsPatterson Matthew RNJOCOOS-1611.400-1-259D-49-10-1-1-5-61234359-24-14
6/20/08 16:18
6/18/08
FOLDAmicus Therapeutics IncDEHealthDrugPharmaceutical PreparationsPatterson Matthew RNJOCOOS.m-2111.010-2-360D-9-2801275-2-9-22744-32-33
6/18/08 16:30
6/16/08
FOLDAmicus Therapeutics IncDEHealthDrugPharmaceutical PreparationsPatterson Matthew RNJOCOOS.m-7511.160-7-1060D-16-301059601-62441-30-26
4/16/08 17:22
4/14/08
FOLDAmicus Therapeutics IncDEHealthDrugPharmaceutical PreparationsPatterson Matthew RNJOCOOS.m-4610.180-5-666D-44-8-1-13-10-50-722522-16
4/16/08 17:17
4/14/08
FOLDAmicus Therapeutics IncDEHealthDrugPharmaceutical PreparationsPatterson Matthew RNJOCOOS-5810.480-6-771D-44-8-1-13-10-50-722522-16

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact